Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006486 · ClinicalTrials.gov registry record · Phase 2
Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
- 335
- Enrollment target
NCT00006486: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT00006486 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 335 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (152% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006486, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 335 participants
- Enrollment target
Study Summary
Randomized phase II trial to study the effectiveness of carboxyamidotriazole in treating patients who have metastatic kidney cancer. Carboxyamidotriazole may stop the growth of kidney cancer by stopping blood flow to the tumor
Interventions
- OTHER placebo
- DRUG carboxyamidotriazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2000-10 |
| Phase | Phase 2 |
What the finished NCT00006486 record still lists
NCT00006486 is an interventional study that assigns participants to a tested intervention. The registered 335 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (152% higher).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00006486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006486 about?
NCT00006486 is a clinical study titled "Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer". Randomized phase II trial to study the effectiveness of carboxyamidotriazole in treating patients who have metastatic kidney cancer. Carboxyamidotriazole may stop the growth of kidney cancer by stopping blood flow to the tumor
What is the current status of trial NCT00006486?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 335 participants. The study started on 2000-10.
What interventions are being tested in trial NCT00006486?
The interventions under investigation include: placebo (OTHER), carboxyamidotriazole (DRUG).
Who is sponsoring clinical trial NCT00006486?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00006486's enrollment target sits among peer trials
335 142nd of 2000 higher than 1,858 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134754 · 335 participants · NA
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
- NCT05554406 · 335 participants · Phase 2
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- NCT06183437 · 335 participants · Phase 4
The STOP-MED CTRCD Trial
- NCT06885177 · 335 participants · NA
TECTONIC CAD IVL IDE Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia